Goulart BHL, Mushti SL, Chatterjee S, Larkins E, et al. Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis. Lancet Oncol 2024 Mar 5:S1470-2045(24)00040.
PMID: 38458207